Targeting chronic endometritis: study reveals potential diagnostic markers

FHS
July 25, 2023
1:32 pm

Researchers investigated the gene expression signatures and immune cell involvement in chronic endometritis (CE) for potential diagnostic markers.

Bristol ‘take-under’ of Mirati is not so great for biotech, but company’s new cancer target has potential

Some day-after thoughts on Bristol Myers Squibb acquiring Mirati Therapeutics: A take-under deal feels meh for biotech sector sentiment. Bristol is paying $58 per share

October 9, 2023

Cannabinoids for weight loss, a cancelled ad comm, and the Fed lowers interest rates

Are generalist investors good or bad for biotech? How did Elaine and Adam’s trip to New York go? And how long has George Church owned

September 19, 2024

Physical activity and sleep patterns change sharply when young adults begin work

When young adults start working, the amount of daily physical activity they do increases sharply, only to fall away again over the new few years,

January 28, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.